Verition Fund Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $711K | Buy |
50,809
+37,080
| +270% | +$519K | ﹤0.01% | 2054 |
|
|
2025
Q1 | $187K | Sell |
13,729
-8,872
| -39% | -$121K | ﹤0.01% | 2400 |
|
|
2024
Q4 | $461K | Buy |
+22,601
| New | +$461K | ﹤0.01% | 1933 |
|
|
2023
Q3 | – | Sell |
-8,898
| Closed | -$263K | – | 2045 |
|
|
2023
Q2 | $263K | Sell |
8,898
-2,884
| -24% | -$85.1K | ﹤0.01% | 1429 |
|
|
2023
Q1 | $271K | Buy |
+11,782
| New | +$271K | ﹤0.01% | 1454 |
|